Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K
Peptide therapy reintroduces bioidentical peptides to restore function, balance, and optimal performance at the cellular level
However, standard guidelines are not yet unified
Further experiments have demonstrated that the peptide is capable of suppressing the activity of pro-inflammatory and fibrotic factors characteristic of the senescence-associated secretory phenotype (SASP), thereby contributing to the restoration of damaged tissue microenvironments
The situation becomes more concerning for diabetic patients using these medications, as their risk of intestinal obstruction jumps 4.5 times higher compared to those using other glucose control options